Realizing the potential of cancer prevention - The role of implementation science

New England Journal of Medicine

Volumn 376, Issue 10, 2017, Pages 986-990

  Emmons, Karen M ^a   Colditz, Graham A ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ALCOHOL ABUSE; BREAST CANCER; CANCER IMMUNIZATION; CANCER MORTALITY; CANCER PREVENTION; CHRONIC LIVER DISEASE; DRUG ABUSE; ENVIRONMENTAL POLICY; GENE MUTATION; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; LIVER CANCER; LUNG CANCER; MEDICAL RESEARCH; MENTAL HEALTH; MENTAL HEALTH CARE; OBESITY; OVARY CANCER; PHYSICAL INACTIVITY; PREVALENCE; REVIEW; RISK REDUCTION; SALPINGOOOPHORECTOMY; SMOKING BAN; SMOKING CESSATION; TOBACCO USE; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; WART VIRUS; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEALTH CARE POLICY; MASS COMMUNICATION; NEOPLASMS; TRANSLATIONAL RESEARCH;

DELIVERY OF HEALTH CARE; DIFFUSION OF INNOVATION; EVIDENCE-BASED MEDICINE; HEALTH POLICY; HUMANS; NEOPLASMS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 85015642839     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMsb1609101     Document Type: Review

References (47)

1. Willett WC, Colditz GA, Mueller NE. Strategies for minimizing cancer risk. Sci Am 1996;275:88-91, 94-5.
2. Colditz GA, DeJong D, Emmons K, Hunter DJ, Mueller N, Sorensen G. Harvard report on cancer prevention. Volume 2: prevention of human cancer. Cancer Causes Control 1997;8:Suppl 1:S1-S50.
3. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66:1191-308.
4. Colditz GA, Wolin KY, Gehlert S. Applying what we know to accelerate cancer prevention. Sci Transl Med 2012;4:127rv4.
5. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149:627-37.
6. Koh HK, Sebelius KG. Ending the tobacco epidemic. JAMA 2012;308:767-8.
7. The health consequences of smoking - 50 years of progress: a report of the Surgeon General. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014 (https://www.surgeongeneral.gov/library/reports/50-years-of-progress/).
8. Chaloupka FJ, Yurekli A, Fong GT. Tobacco taxes as a tobacco control strategy. Tob Control 2012;21:172-80.
9. Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies: IARC Working Group on evaluation of cervical cancer screening programmes. Br Med J (Clin Res Ed) 1986;293:659-64.
10. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011;377:2085-92.
11. Gertig DM, Brotherton JM, Budd AC, Drennan K, Chappell G, Saville AM. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study. BMC Med 2013;11:227.
12. Giuliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 2011;364:401-11.
13. Chiang CJ, Yang YW, You SL, Lai MS, Chen CJ. Thirty-year outcomes of the national hepatitis B immunization program in Taiwan. JAMA 2013;310:974-6.
14. Rebbeck TR, Kauff ND, Domchek SM. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 2009;101:80-7.
15. Bevers TB, Ward JH, Arun BK, et al. Breast cancer risk reduction, version 2.2015. J Natl Compr Canc Netw 2015;13:880-915.
16. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 2005;97:1652-62.
17. Martino S, Cauley JA, Barrett-Connor E, et al. Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst 2004;96:1751-61.
18. CDC Fact sheet: viral hepatitis and liver cancer. Atlanta: Centers for Disease Control and Prevention, Department of Health and Human Services, 2016.
19. Ward B, Clarke T, Nugent C, Schiller JT. Early release of selected estimates based on data From the 2015 National Health Interview Survey. Atlanta: National Center for Health Statistics, May 2016 (https://www.cdc.gov/nchs/data/nhis/earlyrelease/earlyrelease201605.pdf).
20. Centers for Disease Control and Prevention. BRFSS Prevalence and Trends data. 2016 (https://www.cdc.gov/brfss/brfssprevalence/index.html).
21. Centers for Disease Control and Prevention. Youth Risk Behavior Surveillance System data. 2016 (https://nccd.cdc.gov/youthonline/App/Default.aspx).
22. Centers for Disease Control and Prevention. Chronic Disease Indicators (CDI) data. 2016 (http://nccd.cdc.gov/cdi).
23. Moore LV, Thompson FE. Adults meeting fruit and vegetable intake recommendations - United States, 2013. MMWR Morb Mortal Wkly Rep 2015;64:709-25.
24. Reagan-Steiner S, Yankey D, Jeyarajah J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2015. MMWR Morb Mortal Wkly Rep 2016;65:850-8.
25. Hill HA, Elam-Evans LD, Yankey D, Singleton JA, Kolasa M. National, state, and selected local area vaccination coverage among children aged 19-35 months - United States, 2014. MMWR Morb Mortal Wkly Rep 2015;64:889-96.
26. Brownson RC, Haire-Joshu D, Luke DA. Shaping the context of health: a review of environmental and policy approaches in the prevention of chronic diseases. Annu Rev Public Health 2006;27:341-70.
27. Boonn A. State cigarette excise tax rates & rankings. Washington, DC: Campaign for Tobacco-Free Kids, 2016 (http://www.tobaccofreekids.org/research/factsheets/pdf/0097.pdf).
28. Fiore MC, Jaén CR. A clinical blueprint to accelerate the elimination of tobacco use. JAMA 2008;299:2083-5.
29. McAfee T, Babb S, McNabb S, Fiore MC. Helping smokers quit - opportunities created by the Affordable Care Act. N Engl J Med 2015;372:5-7.
30. Byers T, Wender RC, Jemal A, Baskies AM, Ward EE, Brawley OW. The American Cancer Society challenge goal to reduce US cancer mortality by 50% between 1990 and 2015: results and reflections. CA Cancer J Clin 2016;66:359-69.
31. Altice CK, Banegas MP, Tucker-Seeley RD, Yabroff KR. Financial hardships experienced by cancer survivors: a systematic review. J Natl Cancer Inst 2016;109(2):djw205.
32. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011;103:117-28.
33. Xu X, Bishop EE, Kennedy SM, Simpson SA, Pechacek TF. Annual healthcare spending attributable to cigarette smoking: an update. Am J Prev Med 2015;48:326-33.
34. Richard P, West K, Ku L. The return on investment of a Medicaid tobacco cessation program in Massachusetts. PLoS One 2012;7(1):e29665.
35. Rabin BA, Glasgow RE, Kerner JF, Klump MP, Brownson RC. Dissemination and implementation research on community-based cancer prevention: a systematic review. Am J Prev Med 2010;38:443-56.
36. Emmons KM, Thompson B, McLerran D, et al. The relationship between organizational characteristics and the adoption of workplace smoking policies. Health Educ Behav 2000;27:483-501.
37. Emmons KM, Biener L. The impact of organizational characteristics on smoking policy restrictions in midwestern hospitals. Am J Health Promot 1993;8:43-9.
38. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA 2000;284:2606-10.
39. Shi Y, Cummins SE. Smoking cessation services and smoke-free policies at substance abuse treatment facilities: national survey results. Psychiatr Serv 2015;66:610-6.
40. Data spotlight:U.S. Department of Health and Human Services. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014.
41. Himelhoch S, Daumit G. To whom do psychiatrists offer smoking-cessation counseling? Am J Psychiatry 2003;160:2228-30.
42. Krauth D, Apollonio DE. Overview of state policies requiring smoking cessation therapy in psychiatric hospitals and drug abuse treatment centers. Tob Induc Dis 2015;13:33.
43. Warnecke RB, Oh A, Breen N, et al. Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities. Am J Public Health 2008;98:1608-15.
44. Martinez-Gutierrez J, Jhingan E, Angulo A, Jimenez R, Thompson B, Coronado GD. Cancer screening at a federally qualified health center: a qualitative study on organizational challenges in the era of the patient-centered medical home. J Immigr Minor Health 2013;15:993-1000.
45. Liang S, Kegler MC, Cotter M, et al. Integrating evidence-based practices for increasing cancer screenings in safety net health systems: a multiple case study using the Consolidated Framework for Implementation Research. Implement Sci 2016;11:109.
46. Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci 2009;4:50.
47. Institute of Medicine. Spread, scale, and sustainability in population health: workshop summary. Washington, DC: National Academies Press, 2015.